Displaying all 3 publications

Abstract:
Sort:
  1. Wong SM, Tang JJ
    Med Mycol, 2012 May;50(4):404-6.
    PMID: 22074310 DOI: 10.3109/13693786.2011.630684
    Disseminated sporotrichosis is uncommon and usually occurs in patients who are immunodeficient. Here we describe a male patient who was otherwise in good physical condition, who presented with disseminated sporotrichosis. The only significant event in his past medical history was lepromatous leprosy which had been treated 42 years earlier.
    Matched MeSH terms: Leprosy, Lepromatous/drug therapy
  2. Gill HK, Ridley DS, Ganesan J, Mustafa AS, Rees RJ, Godal T
    Lepr Rev, 1990 Mar;61(1):25-31.
    PMID: 2181222
    The proliferative responses of peripheral blood mononuclear cells (PBMC) to Mycobacterium leprae and BCG were studied in two groups of leprosy patients: a group of 8 lepromatous patients who had been on treatment for more than 20 years (TLL) and a group of 8 untreated lepromatous leprosy patients (ULL). The mean response to M. leprae of the TLL group was 6195 cpm with 5 of the 8 patients responding positively. The mean response to M. leprae of the ULL group was 617 cpm, with only 1 patient showing a positive response. The corresponding proliferative responses to BCG were 19,908 cpm in the TLL group and 7908 in the ULL group. Thirteen M. leprae reactive clones were established from 2 TLL patients and 5 M. leprae reactive clones were established from 2 tuberculoid leprosy patients. Seven of these clones, 4 from the TLL patients and 3 from the tuberculoid (TT) patients could be studied further. Three of the TLL clones responded specifically to M. leprae, while one of the clones exhibited a broad cross-reactivity to other mycobacteria. All of these clones were of the CD4+CD8- phenotype. Our findings suggest that responsiveness to M. leprae can be detected in vitro in a proportion of LL patients who have undergone prolonged chemotherapy, and that this response involves M. leprae reactive CD8+CD8- T cells, of which some appear to be specific to M. leprae.
    Matched MeSH terms: Leprosy, Lepromatous/drug therapy
  3. El Beltagi AH, El-Nil H, Alrabiah L, El Shammari N
    Clin Imaging, 2012 Mar-Apr;36(2):142-5.
    PMID: 22370135 DOI: 10.1016/j.clinimag.2011.07.004
    Leprosy is a granulomatous disease primarily affecting the skin and peripheral nerves caused by Mycobacterium leprae, but also significantly involving sinonasal cavities and cranial nerves. It continues to be a significant public health problem, and despite multidrug therapy, it can still cause significant morbidity. The awareness of cranial nerve, intracranial and orbital apex involvement as in our case is important for appropriate treatment measures.
    Matched MeSH terms: Leprosy, Lepromatous/drug therapy
Filters
Contact Us

Please provide feedback to Administrator ([email protected])

External Links